
DTx Plus, Inc. is pioneering an AI-powered digital therapeutics platform designed for remote patient monitoring and management of chronic diseases, particularly Congestive Heart Failure (CHF). The platform, featuring a voice-enabled assistant named Carrie, provides touchless care management, predictive analytics, and real-time insights for physicians, enhancing patient engagement and adherence to treatment protocols. By leveraging advanced AI technologies, DTx Plus aims to reduce hospital admissions and improve patient outcomes, positioning itself as a leader in the digital healthcare space.

DTx Plus, Inc. is pioneering an AI-powered digital therapeutics platform designed for remote patient monitoring and management of chronic diseases, particularly Congestive Heart Failure (CHF). The platform, featuring a voice-enabled assistant named Carrie, provides touchless care management, predictive analytics, and real-time insights for physicians, enhancing patient engagement and adherence to treatment protocols. By leveraging advanced AI technologies, DTx Plus aims to reduce hospital admissions and improve patient outcomes, positioning itself as a leader in the digital healthcare space.
Headquarters: Princeton, New Jersey, United States
Product: Carrie — AI-powered digital therapeutics / conversational care companion
Focus: Remote patient monitoring and chronic disease management (notably CHF)
Team size: 23 employees
Funding stage: Pre-Seed (lead: Nitin Doshi)
Digital therapeutics and care-management workflows for chronic disease (remote monitoring and patient engagement).
2023
Healthcare SaaS / Digital Therapeutics
Pre-seed round listed with lead investor; specific amount obfuscated in profiles.